| Dr Kesav G Nair, MD | |
|
40 Cross St, 4th Fl, Norwalk, CT 06851-4647 | |
| (203) 845-4898 | |
| (203) 845-4897 |
| Full Name | Dr Kesav G Nair |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Medical Oncology |
| Location | 40 Cross St, Norwalk, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104811132 | NPI | - | NPPES |
| 001207224 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 020722 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kesav G Nair, MD 40 Cross St, 4th Fl, Norwalk, CT 06851-4647 Ph: (203) 845-4898 | Dr Kesav G Nair, MD 40 Cross St, 4th Fl, Norwalk, CT 06851-4647 Ph: (203) 845-4898 |
News Archive
According to a new study, women can accurately recall key pregnancy-related information at least 4 years later that could have important implications for their future risk of developing cardiovascular disease (CVD).
Data from a clinical trial has shown that how people respond to treatment for Bipolar Disorder may be influenced by their weight and the overall quality of their diet, including whether they are eating a diet high in foods thought to contribute to general inflammation.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 8 days ago
Dr. Eve Block, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2665 Fax: 203-739-8878 | |
Vittoria Gassman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 120 Connecticut Ave, Norwalk Community Health Center, Norwalk, CT 06854 Phone: 203-899-1770 | |
Dr. Yonatan J Hillman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Stevens St Ste D, Norwalk, CT 06850 Phone: 203-852-3455 | |
Maria A Martin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Xiaofei Wei, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Daniel Ethan Boxer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-845-4811 Fax: 203-845-4897 | |
Dr. Caitlyn Kuwata, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2025 |